| Menopausal syndrome
Bijuva vs Veozah
Side-by-side clinical, coverage, and cost comparison for menopausal syndrome.Deep comparison between: Bijuva vs Veozah with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.Safety signalsVeozah has a higher rate of injection site reactions vs Bijuva based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Veozah but not Bijuva, including UnitedHealthcare
Sign up to reveal the full AI analysis
Category
Bijuva
Veozah
At A Glance
Oral
Daily
Estrogen-progesterone combination
Oral
Daily
NK3 receptor antagonist
Indications
- Menopausal syndrome
- Menopausal syndrome
Dosing
Menopausal syndrome Start with 0.5 mg estradiol/100 mg progesterone orally once each evening with food; adjust dose based on clinical response; attempt to taper or discontinue at 3 to 6 month intervals.
Menopausal syndrome 45 mg tablet orally once daily with or without food.
Contraindications
- Abnormal genital bleeding of unknown etiology
- Breast cancer or history of breast cancer
- Estrogen-dependent neoplasia
- Active deep vein thrombosis (DVT), pulmonary embolism (PE), or history of these conditions
- Active arterial thromboembolic disease (stroke, myocardial infarction) or history of these conditions
- Known anaphylactic reaction, angioedema, or hypersensitivity to BIJUVA
- Hepatic impairment or disease
- Known thrombophilic disorders, such as protein C, protein S, or antithrombin deficiency
- Known cirrhosis
- Severe renal impairment or end-stage renal disease
- Concomitant use with CYP1A2 inhibitors
Adverse Reactions
Most common (>=3%) Breast tenderness, headache, nausea, vaginal bleeding, vaginal discharge, pelvic pain
Serious Cardiovascular disorders, malignant neoplasms
Postmarketing Abdominal pain, abdominal distention, diarrhea, vomiting, fatigue, malaise, weight increased, fluid retention, muscle spasms, pain in extremity, dizziness, somnolence, insomnia, sleep disorder, breast pain, uterine bleeding, night sweats, pruritus, hot flush
Most common (>=2%) Abdominal pain, diarrhea, insomnia, back pain, hot flush, hepatic transaminase elevation
Serious Hepatic transaminase elevation and hepatotoxicity
Postmarketing Serious drug-induced hepatotoxicity with elevated transaminases, alkaline phosphatase, and bilirubin, coupled with fatigue, nausea, pruritus, jaundice, pale feces, and dark urine
Pharmacology
Estrogen-progesterone combination; estradiol binds nuclear estrogen receptors to reduce elevated gonadotropin levels and maintain secondary sexual characteristics in postmenopausal women, while progesterone binds progesterone receptors to transform proliferative endometrium into secretory endometrium and oppose estrogen actions.
Fezolinetant is an NK3 receptor antagonist that blocks neurokinin B binding on kisspeptin/neurokinin B/dynorphin neurons to modulate neuronal activity in the thermoregulatory center, with >450-fold selectivity for NK3 over NK1 or NK2 receptors.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Bijuva
- Covered on 5 commercial plans
- PA (2/12) · Step Therapy (0/12) · Qty limit (4/12)
Veozah
- Covered on 5 commercial plans
- PA (9/12) · Step Therapy (9/12) · Qty limit (10/12)
UnitedHealthcare
Bijuva
- Covered on 4 commercial plans
- PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
Veozah
- Covered on 4 commercial plans
- PA (6/8) · Step Therapy (4/8) · Qty limit (6/8)
Humana
Bijuva
- Covered on 0 commercial plans
- PA (1/3) · Step Therapy (0/3) · Qty limit (2/3)
Veozah
- Covered on 0 commercial plans
- PA (3/3) · Step Therapy (2/3) · Qty limit (2/3)
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Bijuva.
No savings programs available for Veozah.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
- Verify eligibility with the payer.
- Pull the right PA forms directly from the payer.
- Submit, track & send live updates to your dashboard.
Free to start · HIPAA compliant
Next Steps for Your Patient
BijuvaView full Bijuva profile
VeozahView full Veozah profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.